Low testosterone levels, depressive symptoms, and falls in older men: A cross-sectional study

Journal of the American Medical Directors Association

Volumn 15, Issue 1, 2014, Pages 30-35

  Kurita, Noriaki ^a   Horie, Shigeo ^b,c   Yamazaki, Shin ^a   Otoshi, Kenichi ^d   Otani, Koji ^d   Sekiguchi, Miho ^d   Onishi, Yoshihiro ^e   Takegami, Misa ^f   Ono, Rei ^g   Konno, Shin ichi ^d   Kikuchi, Shin ichi ^d   Fukuhara, Shunichi ^a,d  

^a KYOTO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e Institute for Health Outcomes and Process Evaluation Research   (Japan)

^f NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^g KOBE UNIVERSITY   (Japan)

Author keywords

Depression; Fall; Testosterone

Indexed keywords

TESTOSTERONE;

ADULT; AGED; ANDROGEN DEFICIENCY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALLING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL MOBILITY; SALIVA LEVEL; SELF REPORT; SOCIAL STATUS; TESTOSTERONE BLOOD LEVEL;

DEPRESSION; FALL; TESTOSTERONE;

ACCIDENTAL FALLS; AGED; CROSS-SECTIONAL STUDIES; DEPRESSION; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; SALIVA; TESTOSTERONE;

EID: 84890591818     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.11.003     Document Type: Article

References (38)

1. Tinetti M.E., Speechley M., Ginter S.F. Risk factors for falls among elderly persons living in the community. NEngl J Med 1988, 319:1701-1707.
2. Rubenstein L.Z., Josephson K.R. The epidemiology of falls and syncope. Clin Geriatr Med 2002, 18:141-158.
3. Moreland J.D., Richardson J.A., Goldsmith C.H., Clase C.M. Muscle weakness and falls in older adults: A systematic review and meta-analysis. JAm Geriatr Soc 2004, 52:1121-1129.
4. Tromp A.M., Smit J.H., Deeg D.J.H., et al. Predictors for falls and fractures in the longitudinal aging study Amsterdam. JBone Miner Res 1998, 13:1932-1939.
5. Kurita N., Yamazaki S., Fukumori N., et al. Overactive bladder symptom severity is associated with falls in community-dwelling adults: LOHAS study. BMJ Open 2013, 3:e002413. http://dx.doi.org/10.1136/bmjopen-2012-002413.
6. Allan C.A., McLachlan R.I. Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol 2004, 60:653-670.
7. Krasnoff J.B., Basaria S., Pencina M.J., et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: The Framingham Offspring Study. JClin Endocrinol Metab 2010, 95:2790-2799.
8. Roy T.A., Blackman M.R., Harman S.M., et al. Inter-relationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinold Metabol 2002, 283:E284-E294.
9. Bischoff-Ferrari H.A., Orav E.J., Dawson-Hughes B. Additive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and women. Osteoporosis Int 2008, 19:1307-1314.
10. Orwoll E., Lambert L.C., Marshall L.M., et al. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006, 166:2124-2131.
11. Szulc P., Claustrat B., Marchand F., Delmas P.D. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: The MINOS Study. JClin Endocrinol Metab 2003, 88:5240-5247.
12. Joshi D., Van Schoor N.M., De Ronde W., et al. Low free testosterone levels are associated with prevalence and incidence of depressive symptoms in older men. Clin Endocrinol 2010, 72:232-240.
13. Schaap L.A., Pluijm S.M., Smit J.H., et al. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol (Oxf) 2005, 63:152-160.
14. Gooren L.J., Behre H.M., Saad F., et al. Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research. Aging Male 2007, 10:173-181.
15. Gruenewald D.A., Matsumoto A.M. Testosterone supplementation therapy for older men: Potential benefits and risks. JAm Geriatr Soc 2003, 51:101-115.
16. Otani K., Takegami M., Fukumori N., et al. Locomotor dysfunction and risk of cardiovascular disease, quality of life, and medical costs: design of the Locomotive Syndrome and Health Outcome in Aizu Cohort Study (LOHAS) andbaseline characteristics of the study population. JOrthop Sci 2012, 17:261-271.
17. IBL International GmbH. Testosteron Saliva ELISA. Available at: Accessed September 17,2013. http://www.ibl-international.com/media/catalog/product/R/E/RE52631_IFU_en_Testosteron_Saliva_ELISA_2013-04_sym3.pdf.
18. Andresen E.M., Malmgren J.A., Carter W.B., Patrick D.L. Screening for depression in well older adults-Evaluation of a short-form of the CES-D. Am J Prev Med 1994, 10:77-84.
19. Mino Y., Aoyama H., Froom J. Depressive disorders in Japanese primary care patients. Fam Pract 1994, 11:363-367.
20. Lopes A.A., Albert J.M., Young E.W., et al. Screening for depression in hemodialysis patients: Associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int 2004, 66:2047-2053.
21. Ganz D.A., Higashi T., Rubenstein L.Z. Monitoring falls in cohort studies of community-dwelling older people: Effect of the recall interval. JAm Geriatr Soc 2005, 53:2190-2194.
22. Seino Y., Nanjo K., Tajima N., et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. JDiabetes Investig 2010, 1:212-228.
23. van Iersel M.B., Munneke M., Esselink R.A.J., et al. Gait velocity and the Timed-Up-and-Go test were sensitive to changes in mobility in frail elderly patients. JClin Epidemiol 2008, 61:186-191.
24. Akaike H. Anew look at the statistical model identification. IEEE Trans Automatic Control 1974, 19:716-723.
25. Bennette C., Vickers A. Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents. BMC Med Res Methodol 2012, 12:21.
26. Yasuda M., Honma S., Furuya K., et al. Diagnostic significance of salivary testosterone measurement revisited: Using liquid chromatography/mass spectrometry and enzyme-linked immunosorbent assay. JMens Health 2008, 5:56-65.
27. Salminen E.K., Portin R.I., Koskinen A., et al. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 2004, 10:7575-7582.
28. Thilers P.P., MacDonald S.W.S., Herlitz A. The association between endogenous free testosterone and cognitive performance: A population-based study in 35to 90 year-oldmen and women. Psychoneuroendocrinology 2006, 31:565-576.
29. Arregger A.L., Contreras L.N., Tumilasci O.R., et al. Salivary testosterone: A reliable approach to the diagnosis of male hypogonadism. Clin Endocrinol 2007, 67:656-662.
30. Gavrilova N., Lindau S.T. Salivary sex hormone measurement in a national, population-based study of older adults. JGerontol Ser B Psychol Sci Soc Sci 2009, 64B:i94-i105.
31. Wang C., Plymate S., Nieschlag E., Paulsen C.A. Salivary testosterone in men- Further evidence of a direct correlation with free serum testerone. JClin Endocrinol Metab 1981, 53:1021-1024.
32. Wang C., Nieschlag E., Swerdloff R., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008, 159:507-514.
33. Hong D., Kim Y.-S., Son E.S., et al. Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men. Maturitas 2013, 74:148-153.
34. Gröschl M. Current status of salivary hormone analysis. Clin Chem 2008, 54:1759-1769.
35. Granger D.A., Shirtcliff E.A., Booth A., et al. The "trouble" with salivary testosterone. Psychoneuroendocrinology 2004, 29:1229-1240.
36. Thapa P.B., Gideon P., Cost T.W., et al. Antidepressants and the risk of falls among nursing home residents. NEngl J Med 1998, 339:875-882.
37. Giltay E.J., Enter D., Zitman F.G., et al. Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study. JPsychosom Res 2012, 72:205-213.
38. Arden N.K., Nevitt M.C., Lane N.E., et al. Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Arthritis Rheum 1999, 42:1378-1385.